Human Serum Albumin Based Nanodrug Delivery Systems: Recent Advances and Future Perspective
Human Serum Albumin Based Nanodrug Delivery Systems: Recent Advances and Future Perspective
About this item
Full title
Author / Creator
Publisher
Basel: MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
Basel: MDPI AG
Subjects
More information
Scope and Contents
Contents
With the success of several clinical trials of products based on human serum albumin (HSA) and the rapid development of nanotechnology, HSA-based nanodrug delivery systems (HBNDSs) have received extensive attention in the field of nanomedicine. However, there is still a lack of comprehensive reviews exploring the broader scope of HBNDSs in biomedic...
Alternative Titles
Full title
Human Serum Albumin Based Nanodrug Delivery Systems: Recent Advances and Future Perspective
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10459149
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10459149
Other Identifiers
ISSN
2073-4360
E-ISSN
2073-4360
DOI
10.3390/polym15163354